US Defense Department Funds Program for IC14 in Neurotrauma

December 20, 2020
Posted in Company News
December 20, 2020 Implicit Bioscience

The US Department of Defense has funded a USD 735,000 grant entitled “Danger Signalling, Traumatic Brain Injury (TBI), and Epileptogenesis” to Professor David Reutens at the Centre for Advanced Imaging, University of Queensland.

This work will investigate the potential use of Implicit Bioscience’s IC14 as a treatment for TBI to prevent the onset of epilepsy.

10% of all TBIs result in early onset of epileptic seizures.

This problem is of increasing importance in military veterans who may suffer serious TBIs following blast injury or high energy impacts on protective helmets.

TBIs also may lead to later-onset neurodegenerative diseases such as Alzheimer’s disease, an indication which is also within Implicit’s frame of interest for IC14 development.